On Thursday, Alembic Pharmaceuticals announced that it has received final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Desipramine Hydrochloride tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg & 150 mg.